Health
“Which is why we can now advise patients to take 3 packs of combined pills, just the active ones in a row, and just have one withdrawal bleed every 3 months. That means more stable hormones, fewer swings. And the data on this so far shows it is as safe and effective as having the withdrawal bleed every month." (Caption: "Don't Take the…”
Plain restatementTaking three consecutive packs of active monophasic combined oral contraceptive pills before a hormone-free interval ("tricycling"), producing a withdrawal bleed roughly every three months, is comparable in safety and contraceptive effectiveness to the standard 21-days-on, 7-days-off regimen.
General information only - not medical advice.
The main point in this video checks out. Taking three packs of active combined contraceptive pills back to back, known as tricycling, is a recognised regimen in UK and Australasian clinical guidelines, and the best available trial evidence found extended regimens broadly similar to the standard monthly regimen on bleeding, satisfaction and discontinuation. It is also correct that the monthly bleed on the pill is a hormone withdrawal bleed rather than a true period. However, the video leaves out things the guidelines insist on telling people: tricycling is off-label, it applies to monophasic combined pills rather than all contraception, and breakthrough bleeding is common on extended regimens. The research reference given in the caption, PMID 24109198, is a survey of what clinicians prescribe, not a study of safety or effectiveness, so the claim is right but the citation does not support it. The caption's instruction that nobody should take the placebo pills is stronger than guidelines, which present this as a personal choice after being informed about both options. Long term comparative safety data remain limited, and the video's historical explanation about the pill's design was not verified here. This is general information only and not medical advice; decisions about changing how you take a prescribed contraceptive should be made with your own prescriber.
[drifted from the evidence:] Which is why we can now advise patients to take 3 packs of combined pills, [drifted from the evidence:] just the active ones in a [drifted from the evidence:] row, and just have one withdrawal bleed every [drifted from the evidence:] 3 months. [drifted from the evidence:] That means more stable hormones, fewer swings. And the data on this so far shows it is [drifted from the evidence:] as safe and [drifted from the evidence:] effective as having the withdrawal bleed every month." (Caption: "Don't Take the [drifted from the evidence:] Birth Control Dummy Pills")
[added by the neutral restatement:] Taking three consecutive packs of [added by the neutral restatement:] active monophasic combined [added by the neutral restatement:] oral contraceptive pills [added by the neutral restatement:] before a [added by the neutral restatement:] hormone-free interval ("tricycling"), producing a withdrawal bleed [added by the neutral restatement:] roughly every [added by the neutral restatement:] three months, is [added by the neutral restatement:] comparable in safety and [added by the neutral restatement:] contraceptive effectiveness to the [added by the neutral restatement:] standard 21-days-on, 7-days-off regimen.
Red-tinted words in the claim drifted from the evidence. Green-tinted words are what a neutral restatement needs.
The trace / claim to source
- Tricycling is a real, named, guideline-recognised regimen, defined essentially as the video describes: three consecutive packs of active monophasic combined pills followed by a short hormone-free interval, producing a bleed roughly every three months.
- Major clinical guidelines (FSRH, RANZCOG, NICE CKS) endorse offering tailored or extended regimens, and FSRH states they can be used safely and may reduce the risk of contraceptive failure.
- The bleed on the combined pill is a hormone-withdrawal bleed, not a true menstrual period, and the endometrium is kept thin by the pill. This is standard, uncontested physiology and is reflected in guideline reasoning for why the hormone-free interval is not medically required.
- The best comparative trial evidence, the Cochrane review, found the extended and traditional regimens broadly similar on bleeding, discontinuation, satisfaction and compliance, and concluded extended or continuous dosing is a reasonable approach.
- The video's final instruction, to discuss tricycling with your provider, is appropriate and consistent with guideline advice that users be informed about both standard and tailored options.
- Citation mismatch. The post cites PMID 24109198 as a source. That paper is a survey of what UK family planning services know and prescribe, not evidence of safety or effectiveness. The correct supporting evidence is the Cochrane review and the FSRH and NICE guidance. The claim is still supported, but not by the reference given.
- Omitted qualifier: off-label status. FSRH and RANZCOG both require that users be told tailored regimens fall outside the product licence. The video omits this entirely.
- Omitted qualifier: pill type. Tricycling guidance applies to monophasic combined pills. The video's framing applies to "birth control" generally, which would incorrectly sweep in phasic combined pills and progestogen-only pills.
- Overstatement in the caption and opening. "Don't Take the Birth Control Dummy Pills" and "absolutely nobody should take placebo pills" go beyond what the guidelines say. Guidelines frame this as a choice to be offered after information about both regimens, based on the user's preference, not as a regimen everyone should abandon. This is prescriptive advice presented as if it were the guideline position.
- Omitted qualifier: unscheduled bleeding. Extended regimens commonly produce breakthrough bleeding or spotting, which is why guideline wording for extended use builds in a break when 3 to 4 days of breakthrough bleeding occurs. The video presents only upside.
- Single-cause historical framing. "Surprise, religion. It has nothing to do with medicine" asserts one exclusive cause for the 21/7 design. The historical record as generally described includes multiple motivations. Not verified here either way.
- Long-term comparative safety. I did not retrieve trial durations, pregnancy rates with confidence intervals, or certainty-of-evidence ratings from the Cochrane review before search capacity was exhausted. Guideline endorsement is strong, but "as safe" is supported mainly by trials of limited duration rather than by long-horizon outcome data.
- "More stable hormones, fewer swings." This mood and symptom claim was not separately verified. Guidelines do support tailored regimens for reducing hormone-withdrawal symptoms such as headaches and pelvic pain, but the video's phrasing is a broader physiological assertion that I did not trace to a source.
- The exact current wording of NICE CKS on tailored regimens. The CKS full text is UK-access restricted and I read it only through a secondary professional summary.
- The John Rock and Catholic Church historical account, which remains uninvestigated here.
The central proposition is consistent with UK and Australasian clinical guidelines. The FSRH guideline is explicit that tailored combined hormonal contraceptive regimens can reduce the frequency of withdrawal bleeds, that suggested tailored regimens using a monophasic ethinylestradiol CHC are described, and that women should be given information about both standard and tailored regimens and be advised that tailored use is outside the product licence. The same guideline material notes that tailored regimens with fewer, shortened or no hormone-free intervals can be used safely to avoid withdrawal bleeds and associated symptoms, and could reduce the risk of contraceptive failure. The RANZCOG guideline describes the same practice under the same name: tailored CHC refers to regimens with fewer or shortened hormone-free intervals including continuous regimens, also known as extended regimens or tricycling; CHC are among the most used medications worldwide and have been extensively studied for effectiveness and safety; and tailored regimens with shortened or no hormone-free interval for three months, known as tricycling, may be prescribed in Australia and New Zealand off licence. The strongest comparative evidence is the Cochrane review of randomised trials comparing continuous or extended administration (more than 28 days of active hormone) against traditional cyclic administration of 21 days of active hormones and 7 days of placebo. Its conclusion is that the continuous or extended-cycle and traditional regimens appeared similar as judged by bleeding, discontinuation rates and reported satisfaction, and that extended-cycle or continuous dosing appears to be a reasonable approach to CHC use. On adherence, when compliance was reported, no difference between 28-day and extended or continuous cycles was found. The specific regimen described in the video matches the published definition. Clinical reference material citing NICE CKS describes tricycling as three packs of 21 active pills taken consecutively followed by a 4-day or 7-day hormone-free interval, and notes that monophasic 21-day pills should be taken either as an extended regimen, continuing packets without a break until 3 to 4 days of breakthrough bleeding occurs, or as a tricycling regimen. NHS local guidance likewise states that an extended or tricycling regimen with a 4-day pill-free interval should be followed, and additional contraception is not required. The specific citation offered in the post, PMID 24109198, does not support the safety and effectiveness claim. It is Sauer et al., "Offering extended use of the combined contraceptive pill: a survey of specialist family planning services," Int J Womens Health 2013, which presents descriptive analyses of knowledge and provision of extended pill use and the relationship between participant characteristics and prescribing patterns. That is a study of what clinicians do and know, not a trial of clinical outcomes.
Complete reasoning
The reply is formatted for pasting into the thread where the claim is circulating.
Ask this case
Answers come only from the case file above; nothing is added.
Is it actually safe to skip the placebo pills and run three packs together?
The main idea checks out. Tricycling, taking three packs of active monophasic combined pills back to back before a short break, is recognised in UK and Australasian guidelines, and the best trial evidence found it broadly similar to the standard regimen on safety, bleeding, satisfaction and discontinuation.
Does this apply to all birth control pills?
No, the case file notes guidance on tricycling applies specifically to monophasic combined pills, not to phasic combined pills or progestogen-only pills. The video's general framing of birth control risks misleading viewers into applying this to pill types it does not cover.
Does the study cited in the video actually prove this is safe and effective?
No. The cited reference, PMID 24109198, is a survey of what UK family planning clinicians know and prescribe, not a study measuring safety or effectiveness. The actual supporting evidence is a separate Cochrane review and guideline material from FSRH and NICE.
Should everyone stop taking the placebo pills, as the video suggests?
The case file says this goes further than the guidelines. FSRH and RANZCOG frame tricycling as a personal choice to be offered after explaining both standard and tailored options, not as something everyone should do, and both require telling users the practice is off-label.
Are there any downsides to tricycling that the video leaves out?
Yes. The investigation notes that breakthrough bleeding or spotting is common with extended regimens, which is why guidelines build in a break after a few days of such bleeding. The video does not mention this and presents only the benefits.